Several vaccine candidates are being tested to help address the ongoing COVID-19 pandemic. Uncertainty remains about key epidemiologic factors to characterize the disease, including true infection rate, proportion of symptomatic cases, and potential for re-infection. As the virus spreads and data continue to develop, the potential role of vaccination will continue to evolve. This presentation will describe some of the data needed to inform vaccination strategies, as well as guide the development and manufacture of future vaccines. Partnerships between public, private, and academic research groups will be essential to ensure rapid and fair deployment of future vaccines, define a research agenda, and balance supply and demand in the early phases of vaccine availability.
Registration is open here.